Our collaboration with NASA and the International Space Station (ISS Labs) allows us to support innovative research on neurodegenerative diseases and other areas in microgravity environments — providing new insights not possible under Earth's gravity.
How does BioCrowd's collaboration with NASA and the ISS benefit research? Our collaboration with NASA and the International Space Station (ISS Labs) allows us to support innovative research on neurodegenerative diseases and other areas in microgravity environments. This unique setting can provide new insights into disease mechanisms and potential treatments that are not possible under Earth's gravity.
Microgravity is used as a research tool that helps study diseases at zero degrees. It allows scientists to evaluate hypotheses about cellular and molecular behavior without the confounding factor of gravity. This can lead to new understandings of how neurodegenerative processes work and how they might be countered.
Research in microgravity can provide unique insights into the fundamental mechanisms of diseases, revealing new aspects leading to potential new therapeutic targets.
We are looking for investors to invest in translational research projects individually by disease target or in a pool. We also want to partner with patient advocacy groups and research institutions for this novel research to address their needs.
BioCrowd works with sponsors — including biotech and pharma companies, investors, patient advocacy groups, foundations, family offices, and grant funding sources — to support principal investigators (PIs) leading research in the sponsored area via our marketplace platform.
In working with researchers, BioCrowd is introducing an accelerator business model for space research. Our role is to connect researchers and early-stage startups working on translational research with scientific and industry experts, IP lawyers, corporations, and communities — to grow and transform businesses and economies with funding, mentorship, in-kind support, and other benefits to help startups succeed.
The goals are to help scientific entrepreneurs find funding, improve their products or services, shorten time to market, improve patients' outcomes, and develop commercially successful products and services for licensing or acquisition.
Access funding, mentorship, and industry connections to advance your microgravity research programs.
Invest in individual disease targets or a diversified pool of space-based translational research programs.
Partner with BioCrowd to advance research into disease areas of priority to your patient community.
Microgravity and the unique environment of the International Space Station (ISS) offer valuable opportunities for studying and potentially improving various diseases and conditions.
BioCrowd supports compliance-first tokenization structures where appropriate and permitted under applicable securities regulations, enabling transparent tracking of milestone achievements across space research programs.
Support groundbreaking research in microgravity environments and help accelerate discoveries that benefit patients on Earth.